Michael PD, Campbell RA. Editorial comment on "A comparison between intravesical Gemcitabine plus Docetaxel and intravesical BCG in the treatment of non-muscle invasive naive urinary bladder cancer: A systematic review and meta-analysis of oncological outcomes". Urology 2025 Feb 10:S0090-4295(25)00139-6. doi: 10.1016/j.urology.2025.
PMID: 39938601